Sunbelt Securities’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$33.5K Buy
10,870
+26
+0.2% +$110 ﹤0.01% 1136
2025
Q4
$39.1K Hold
10,844
﹤0.01% 1061
2025
Q3
$40.9K Hold
10,844
﹤0.01% 1056
2025
Q2
$78.2K Hold
10,844
0.01% 833
2025
Q1
$54.2K Hold
10,844
﹤0.01% 887
2024
Q4
$79.4K Buy
10,844
+8,470
+357% +$64.7K 0.01% 827
2024
Q3
$14.6K Buy
2,374
+1,234
+108% +$8.36K ﹤0.01% 1225
2024
Q2
$7.58K Buy
+1,140
New +$8.41K ﹤0.01% 1320

Other funds holding ALT

Sunbelt Securities's ALT Position: Q1 2026 in Review

Sunbelt Securities increased its Altimmune (ALT) stake by 0.24% in Q1 2026, buying an estimated $110 and bringing the position to 10,870 shares worth $33.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1136.

Sunbelt Securities first reported a position in ALT in Q2 2024 and has held it in 8 quarters since. The position peaked at $79.4K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Sunbelt Securities held 10,870 shares of Altimmune worth $33.5K as of Q1 2026.
  • Sunbelt Securities bought 26 Altimmune shares in Q1 2026, an estimated $110.
  • Altimmune made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #1136 holding.
  • Sunbelt Securities first reported a position in Altimmune in Q2 2024 and has held it in 8 quarters since.
  • Sunbelt Securities's Altimmune position peaked at $79.4K in Q4 2024.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.